Author

Felix F. Konen

Observed names: F F Konen, Felix Franz Konen, Felix Franz Konen, Felix Konen, Konen, Felix

Institution: Medizinische Hochschule Hannover

Observed institutions: Universität Ulm, Medizinische Hochschule Hannover, University Hospital Münster, University Hospital Cologne, Institut für Klinische Neuroimmunologie, Heinrich Heine University Düsseldorf, University of Göttingen, Ludwig-Maximilians-Universität München, RWTH Aachen University

OpenAlex ID: A5113871527

The Influence of Blood Contamination on Cerebrospinal Fluid Diagnostics

2019 · Philipp Schwenkenbecher, Theda Janssen, et al. · Frontiers in Neurology · 41

Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis

2021 · Philipp Schwenkenbecher, Thomas Skripuletz, et al. · Neurology Neuroimmunology & Neuroinflammation · 37

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease

2025 · Thomas Grüter, Carles Gaig, et al. · JAMA Neurology · 14

Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering

2024 · Christopher Nelke, Christina B. Schroeter, et al. · EBioMedicine · 14

Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis

2024 · Christina B. Schroeter, Christopher Nelke, et al. · Acta Neuropathologica · 12

Risk of Epilepsy and Factors Associated With Time to Seizure Remission in Anti-LGI1 Encephalitis

2025 · Tobias Baumgartner, Moritz Freyberg, et al. · Neurology Neuroimmunology & Neuroinflammation · 4

The influence of beta-amyloid and tau proteins on cognitive changes in Parkinson's disease

2026 · Berit Abraham, Sophia Carl, et al. · Parkinsonism & Related Disorders · 2

Immune cell profiling reveals expanded stem cell–like memory T cells in anti-GAD65-associated neurological syndromes

2026 · Sumanta Barman, Saskia Räuber, et al. · Proceedings of the National Academy of Sciences · 2

Exit-Strategien rücken bei Anti-CD20-Therapien in den Fokus

2026 · Felix Konen, Refik Pul, et al. · NeuroTransmitter

Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study

2026 · Laura Duzzi, Nora Möhn, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

C5-Komplement-Inhibitoren bei der therapierefraktären myasthenen Krise

2025 · F F Konen, K F Jendretzky, et al. · Nervenheilkunde

Vergleich von FcRn-Antagonismus und C5 Komplementinhibitionin generalisierter Myasthenia gravis

2025 · N Huntemann, L Gerischer, et al. · Nervenheilkunde

Altered Microglial Polarization Reduces Demyelination in Cerebellar Slices Treated with Serum from Cd20-Depleted Multiple Sclerosis Patients

2025 · Lara-Jasmin Schröder, Felix Franz Konen, et al. · SSRN Electronic Journal

Works count: 14

Citation count: 127

H-index: 5

I10-index: 5